Kenneth Offit

44.3k total citations · 1 hit paper
311 papers, 16.6k citations indexed

About

Kenneth Offit is a scholar working on Genetics, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Kenneth Offit has authored 311 papers receiving a total of 16.6k indexed citations (citations by other indexed papers that have themselves been cited), including 167 papers in Genetics, 121 papers in Pathology and Forensic Medicine and 92 papers in Molecular Biology. Recurrent topics in Kenneth Offit's work include BRCA gene mutations in cancer (141 papers), Genetic factors in colorectal cancer (75 papers) and Cancer Genomics and Diagnostics (71 papers). Kenneth Offit is often cited by papers focused on BRCA gene mutations in cancer (141 papers), Genetic factors in colorectal cancer (75 papers) and Cancer Genomics and Diagnostics (71 papers). Kenneth Offit collaborates with scholars based in United States, Canada and United Kingdom. Kenneth Offit's co-authors include Mark E. Robson, Judy E. Garber, RS Chaganti, Larry Norton, Jaya M. Satagopan, Riccardo Dalla‐Favera, Nathan A. Ellis, Jeff Boyd, Noah D. Kauff and Khédoudja Nafa and has published in prestigious journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Kenneth Offit

296 papers receiving 16.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Risk-Reducing Salpingo-oophorectomy in Women with aBRCA1orBRCA2Mutation

2002 891 citations Noah D. Kauff, Mark E. Robson et al. profile →

Peers

Countries citing papers authored by Kenneth Offit

Since Specialization

Citations

This map shows the geographic impact of Kenneth Offit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenneth Offit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenneth Offit more than expected).

Fields of papers citing papers by Kenneth Offit

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenneth Offit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenneth Offit. The network helps show where Kenneth Offit may publish in the future.

Co-authorship network of co-authors of Kenneth Offit

This figure shows the co-authorship network connecting the top 25 collaborators of Kenneth Offit. A scholar is included among the top collaborators of Kenneth Offit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenneth Offit. Kenneth Offit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Germline DNA Damage Repair Variants and Prognosis of Patients with High-Risk or Metastatic Prostate Cancer 2024 ·Clinical Cancer Research ·Konrad H. Stopsack, Joseph Vijai, (unknown), Jacob E. Berchuck, Yelena Kemel, (unknown), Dory Freeman, Gwo‐Shu Mary Lee, Diana Mandelker, David B. Solit, Michael J. Morris, Kathryn L. Penney, Wassim Abida, Kenneth Offit, Lorelei A. Mucci, Philip W. Kantoff, Mark M. Pomerantz	5
2	Expanded genetic testing of GIST patients identifies high proportion of non-syndromic patients with germline alterations 2023 ·npj Precision Oncology ·Diana Mandelker, Antonio Marra, Nikita Mehta, Pier Selenica, Zarina Yelskaya, Ciyu Yang, (unknown), Miika Mehine, Maksym Misyura, Olca Baştürk, Alicia Latham, Maria I. Carlo, Michael F. Walsh, Zsofia K. Stadler, Kenneth Offit, Chaitanya Bandlamudi, Meera Hameed, Ping Chi, Jorge S. Reis‐Filho, Ozge Ceyhan‐Birsoy	34
3	SNPs at SMG7 Associated with Time from Biochemical Recurrence to Prostate Cancer Death 2022 ·Cancer Epidemiology Biomarkers & Prevention ·Xiaoyu Song, Meng Ru, Zoe Steinsnyder, Kaitlyn Tkachuk, Ryan Kopp, John Sullivan, Zeynep H. Gümüş, Kenneth Offit, Joseph Vijai, Robert J. Klein	3
4	Genetic Predictors for Fecal Propionate and Butyrate-Producing Microbiome Pathway Are Not Associated with Colorectal Cancer Risk: A Mendelian Randomization Analysis 2022 ·Cancer Epidemiology Biomarkers & Prevention ·Yujia Lu, Yu Zhao, Jenny Chang‐Claude, Stephen B. Gruber, Andrea Gsur, Kenneth Offit, Ľudmila Vodičková, Michael O. Woods, Long H. Nguyen, Kaitlin H. Wade, Robert Carreras‐Torres, Vı́ctor Moreno, Daniel D. Buchanan, Michelle Cotterchio, Andrew T. Chan, Amanda I. Phipps, Ulrike Peters, Mingyang Song	3
5	Early age of onset and broad cancer spectrum persist in MSH6- and PMS2-associated Lynch syndrome 2022 ·Genetics in Medicine ·Ying L. Liu, Karen A. Cadoo, Anna Maio, Zalak Patel, Yelena Kemel, Erin Salo‐Mullen, (unknown), (unknown), (unknown), Robert A. Soslow, Ozge Ceyhan‐Birsoy, Diana Mandelker, Maria I. Carlo, Michael F. Walsh, Jinru Shia, Arnold J. Markowitz, Kenneth Offit, Zsofia K. Stadler, Alicia Latham	10
6	Outcome of Pancreatic Cancer Surveillance Among High-Risk Individuals Tested for Germline Mutations in BRCA1 and BRCA2 2019 ·Cancer Prevention Research ·Amethyst Saldia, Sara H. Olson, (unknown), Xiaolin Liang, (unknown), Erin Salo‐Mullen, (unknown), Zsofia K. Stadler, Peter J. Allen, Kenneth Offit, Robert C. Kurtz	5
7	Case–control analysis identifies shared properties of rare germline variation in cancer predisposing genes 2019 ·European Journal of Human Genetics ·Mykyta Artomov, Joseph Vijai, Grace Tiao, Tinu Thomas, Kasmintan A. Schrader, Robert J. Klein, Adam Kieżun, Namrata Gupta, Lauren Margolin, Alexander Stratigos, Ivana K. Kim, Kristen Shannon, Leif W. Ellisen, Daniel A. Haber, Gad Getz, Hensin Tsao, Steven M. Lipkin, David Altshuler, Kenneth Offit, Mark J. Daly	4
8	Toward automation of germline variant curation in clinical cancer genetics 2019 ·Genetics in Medicine ·Vignesh Ravichandran, (unknown), Yelena Kemel, Michael F. Walsh, Karen A. Cadoo, Steven M. Lipkin, Diana Mandelker, Liying Zhang, Zsofia K. Stadler, Mark E. Robson, Kenneth Offit, Joseph Vijai	21
9	Familial Kidney Cancer: Implications of New Syndromes and Molecular Insights 2019 ·European Urology ·Maria I. Carlo, A. Ari Hakimi, Grant D. Stewart, Gennady Bratslavsky, James Brugarolas, Ying‐Bei Chen, W. Marston Linehan, Eamonn R. Maher, Maria J. Merino, Kenneth Offit, Victor E. Reuter, Brian Shuch, Jonathan Coleman	76
10	High-depth whole genome sequencing of an Ashkenazi Jewish reference panel: enhancing sensitivity, accuracy, and imputation 2018 ·Human Genetics ·Todd Lencz, Jin Yu, Cameron D. Palmer, Shai Carmi, Danny Ben‐Avraham, Nir Barzilai, Susan Bressman, Ariel Darvasi, Judy H. Cho, Lorraine N. Clark, Zeynep H. Gümüş, Joseph Vijai, Robert J. Klein, Steven M. Lipkin, Kenneth Offit, Harry Ostrer, Laurie J. Ozelius, Inga Peter, Gil Atzmon, Itsik Pe’er	15
11	Clinical validity assessment of genes frequently tested on hereditary breast and ovarian cancer susceptibility sequencing panels 2018 ·Genetics in Medicine ·Kristy Lee, Bryce A. Seifert, Hermela Shimelis, Rajarshi Ghosh, Stephanie B. Crowley, (unknown), (unknown), Ann Katherine M. Foreman, Deborah Ritter, (unknown), (unknown), Kenneth Offit, Sharon E. Plon, Fergus J. Couch	41
12	Blood Biomarker Levels to Aid Discovery of Cancer-Related Single-Nucleotide Polymorphisms: Kallikreins and Prostate Cancer 2010 ·Cancer Prevention Research ·Robert J. Klein, Christer Halldén, Angel M. Cronin, Alexander Ploner, Fredrik Wiklund, Anders Bjartell, Pär Stattin, Jianfeng Xu, Peter T. Scardino, Kenneth Offit, Andrew J. Vickers, Henrik Grönberg, Hans Lilja	45
13	The 6q22.33 Locus and Breast Cancer Susceptibility 2009 ·Cancer Epidemiology Biomarkers & Prevention ·Tomas Kirchhoff, Zhang-qun Chen, Bert Gold, Prodipto Pal, Mia M. Gaudet, Kristi Kosarin, Douglas A. Levine, Peter K. Gregersen, (unknown), (unknown), Mark E. Robson, Robert J. Klein, Clifford A. Hudis, Larry Norton, Michael Dean, Kenneth Offit	15
14	Risk-Reducing Salpingo-Oophorectomy for the Prevention of BRCA1- and BRCA2-Associated Breast and Gynecologic Cancer: A Multicenter, Prospective Study 2008 ·Journal of Clinical Oncology ·Noah D. Kauff, Susan M. Domchek, Tara M. Friebel, Mark E. Robson, Johanna Lee, Judy E. Garber, Claudine Isaacs, D. Gareth Evans, Henry T. Lynch, Rosalind A. Eeles, Susan L. Neuhausen, Mary B. Daly, Ellen Matloff, Joanne L. Blum, Paul Sabbatini, Richard R. Barakat, Clifford A. Hudis, Larry Norton, Kenneth Offit, Timothy R. Rebbeck	381
15	The Signatures of Autozygosity among Patients with Colorectal Cancer 2008 ·Cancer Research ·Manny D. Bacolod, (unknown), Shuang Wang, Richard Shattock, Sarah F. Giardina, Zhaoshi Zeng, Jinru Shia, Robert F. Stengel, Norman P. Gerry, Josephine Hoh, Tomas Kirchhoff, Bert Gold, Michael F. Christman, Kenneth Offit, William L. Gerald, Daniel A. Notterman, Jürg Ott, Philip B. Paty, Francis Barany	40
16	Ethical and Legal Aspects of Cancer Genetic Testing 2007 ·Seminars in Oncology ·Kenneth Offit, (unknown)	27
17	Localization of Cancer Susceptibility Genes by Genome-wide Single-Nucleotide Polymorphism Linkage-Disequilibrium Mapping 2004 ·Cancer Research ·Nandita Mitra, (unknown), Alex Smith, Shaokun Chuai, Tomas Kirchhoff, Paolo Peterlongo, Khédoudja Nafa, Michael Phillips, Kenneth Offit, Nathan A. Ellis	11
18	Analysis of Mismatch Repair Defects in the Familial Occurrence of Lymphoma and Colorectal Cancer 2002 ·Leukemia & lymphoma ·Julie Teruya‐Feldstein, (unknown), Lawrence Cohen, Leslie Popplewell, Nathan A. Ellis, Kenneth Offit	18
19	Small non-cleaved-cell lymphoma (undifferentiated lymphoma, Burkitt's type) in American adults: results with treatment designed for acute lymphoblastic leukemia 1991 ·The American Journal of Medicine ·David J. Straus, George Y. Wong, John Liu, (unknown), Daniel A. Filippa, Jonathan Gold, Kenneth Offit, Bayard D. Clarkson	41
20	Ki-1 antigen expression defines a favorable clinical subset of non-B cell non-Hodgkin's lymphoma. 1990 ·PubMed ·Kenneth Offit, Marc Ladanyi, (unknown), Salah Ebrahim, D Filippa, R. S. K. Chaganti	44

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact